Sartorius Stedim Biotech S.A.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| DIM.PA | SRT.F | 688289.SS | STVN | AVTR | ALIF-B.ST | |
|---|---|---|---|---|---|---|
| Market cap | 22.23B | 15.64B | 9.15B | 3.67B | 10.60B | 22.79B |
| P/E (TTM) | 68.6 | 71.7 | 83.8 | 22.8 | 31.3 | 35.5 |
| Forward P/E | 37.7 | 34.5 | 20.2 | 16.3 | 17.6 | 58.8 |
| Price/book | 5.1 | 5.8 | 1.3 | 2.0 | 1.8 | 3.8 |
| Dividend yield | 0.31% | 0.32% | 3.36% | 0.46% | — | 0.81% |
| 1-year change | +17.44% | +28.38% | −28.21% | −43.60% | +34.63% | −0.70% |
| Today | +2.15% | −0.66% | +0.89% | −4.68% | +0.38% | +1.36% |
The closest companies by business and industry (Medical Instruments & Supplies). Prices may be delayed up to 15 min.
Latest news
All DIM.PA news ›Sartorius Stedim Biotech S.A. Non-GAAP EPS of €2.84, revenue of €2.29B
Sartorius Stedim Biotech S.A. press release (SDMHF): 9M Non-GAAP EPS of €2.84. Revenue of €2.29B (+4.1% Y/Y). - Sartorius Stedim Biotech S.A. press release (SDMHF): 9M Non-GAAP EPS of €2.84. - Guidance for fiscal year 2026 confirmed and…
Sartorius Stedim Biotech S.A. (SRTOY) Q3 2026 Earnings Call Transcript
Sartorius Stedim Biotech S.A. (SRTOY) Q3 2026 Earnings Call October 22, 2026 7:00 AM EDT Petra Muller - Head of Investor RelationsMichael Grosse - CEO & Chairman of the Executive BoardFlorian Funck - CFO & Member of Executive BoardRene…
Sartorius Stedim Biotech : JP Morgan remains its Buy rating
Published on 10/22/2026 at 08:00 am EDT Sartorius Stedim Biotech: Recovery and Margin Expansion in Sight October 08, 2026 at 10:14 am EDT Option Care Health deal boosts European medical equipment makers Sartorius Stedim Biotech: finally,…
Sartorius Stedim Biotech (SDMHF) Expected to Announce Earnings on Thursday
Posted by Defense World Staff on Oct 15th, 2026 Sartorius Stedim Biotech (OTCMKTS:SDMHF – Get Free Report) is expected to be announcing its results before the market opens on Thursday, October 22nd. Analysts expect Sartorius Stedim Biotech…
AlphaValue's positive view is not enough for Sartorius Stedim Biotech
Sartorius Stedim Biotech fell sharply on the Paris Bourse, down 5.03% at 207.80, despite a relatively positive note from AlphaValue. The stock was hurt by the decline in its parent company Sartorius in Frankfurt, down 5.40%, as well as…
Sartorius Stedim Biotech: Recovery and Margin Expansion in Sight
Nav change Change in target price € 253 vs 238 +6.58% The TP increase reflects upgrades to our DCF and NAV . The investment case remains compelling: consumables-led growth, the now-confirmed... Medical Equipment, Supplies & Distribution…
UBS upgrades Sartorius Stedim Biotech to Buy
Sartorius Stedim Biotech is drawing particular attention on the Paris stock market (+4.59%, at 191.30) in a more cautious market that sees the SBF 120 down 0.17%. The stock is being supported by an upgrade from UBS. Published on…
Sartorius Stedim Biotech: finally, are its troubles ending?
Is this the end of the (too) long agony for the Aubagne-based group? After several quarters of post-Covid normalization, growth has returned in the core business of consumables. This recovery is now reflected in an upward revision of…
Sartorius Stedim Biotech: Total Return chart (Dividends reinvested) - Euronext Paris stock market
See the history of Sartorius Stedim Biotech, with dividends reinvested. (Total Return chart) DIM Stock market Total Return chart Sartorius Stedim Biotech Medical Equipment, Supplies & Distribution Past dividends on Sartorius Stedim Biotech…
Sartorius Stedim Biotech: Official Announcements - Stock Market News
Find the latest press releases and official documents published by Sartorius Stedim Biotech on MarketScreener. Sartorius Stedim Biotech: Recovery and Margin Expansion in Sight October 08, 2026 at 10:14 am EDT Option Care Health deal boosts…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com20
- seekingalpha.com3
- defenseworld.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 24 articles, not a forecast.